Skip to main content

Duffy Sean P.'s Form 4 filing

Omada Health, Inc. (OMDA) · filed Jul 6, 2026

Accession no.
0001610717-26-000322
Filed
Jul 6, 2026, 5:31 PM ET
Trade date
Jul 1, 2026
Filing delay
5 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $587.2K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Duffy Sean P.CIK 0002069522Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2026Common StockMOption exerciseAcquired+12,944$5.82+$75,334.08424,805Direct
Jul 1, 2026Common StockSSaleDisposed−12,944$22.70F2−$293,787.38411,861Direct
Jul 1, 2026Common StockMOption exerciseAcquired+12,942$8.28+$107,159.76424,803Direct
Jul 1, 2026Common StockSSaleDisposed−12,942$22.67F3−$293,435.26411,861Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 1, 2026Common StockMOption exerciseDisposed−12,944$0.00$0155,427Direct
Jul 1, 2026Common StockMOption exerciseDisposed−12,942$0.00$0116,077Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $22.23 to $23.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $22.095 to $22.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)